We are live on ! Find out more
GIM

Greylin Investment Management Portfolio holdings

AUM $598M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+7.5%
1 Year Est. Return
+18.59%
3 Year Est. Return
+52.1%
5 Year Est. Return
+133.23%
10 Year Est. Return
+214.42%
AUM
$417M
AUM Growth
+$15.8M
Cap. Flow
-$10.8M
Cap. Flow %
-2.59%
Top 10 Hldgs %
76.49%
Holding
76
New
2
Increased
13
Reduced
41
Closed
8

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$3.71M
2
GSK icon
GSK
GSK
+$1.94M
3
KMI icon
Kinder Morgan
KMI
+$622K
4
PFE icon
Pfizer
PFE
+$402K
5
VIVO
Meridian Bioscience Inc
VIVO
+$348K

Top Sells

Rank Stock Value
1
USB icon
US Bancorp
USB
+$3.68M
2
LNKD
LinkedIn Corporation
LNKD
+$3.09M
3
PSX icon
Phillips 66
PSX
+$1.9M
4
JOY
Joy Global Inc
JOY
+$1.2M
5
BHI
Baker Hughes
BHI
+$1.17M

Sector Composition

Rank Sector Weight
1 Financials 38.77%
2 Energy 17.96%
3 Healthcare 11.17%
4 Technology 9.5%
5 Consumer Discretionary 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
26
Eli Lilly
LLY
$1.06T
$1.99M 0.48%
27,040
-1,400
-5% -$104K
ABT icon
27
Abbott
ABT
$199B
$1.85M 0.44%
48,255
+1,650
+4% +$65.4K
MTB icon
28
M&T Bank
MTB
$34.9B
$1.84M 0.44%
11,775
-900
-7% -$122K
LOW icon
29
Lowe's Companies
LOW
$119B
$1.69M 0.41%
23,775
-620
-3% -$43.9K
NAT icon
30
Nordic American Tanker
NAT
$1.37B
$1.6M 0.38%
192,150
+1,134
+0.6% +$10.1K
GE icon
31
GE Aerospace
GE
$367B
$1.57M 0.38%
10,356
-209
-2% -$30.4K
PFE icon
32
Pfizer
PFE
$162B
$1.49M 0.36%
48,248
+13,175
+38% +$402K
MU icon
33
Micron Technology
MU
$1.06T
$1.36M 0.33%
62,205
-8,275
-12% -$155K
BHI
34
DELISTED
Baker Hughes
BHI
$1.32M 0.32%
20,400
-19,700
-49% -$1.17M
DD
35
DELISTED
Du Pont De Nemours E I
DD
$1.26M 0.3%
17,235
-1,150
-6% -$81.7K
JPM icon
36
JPMorgan Chase
JPM
$950B
$1.17M 0.28%
13,496
+50
+0.4% +$3.81K
AMBA icon
37
Ambarella
AMBA
$3.05B
$1.15M 0.28%
21,180
-750
-3% -$45.2K
CVX icon
38
Chevron
CVX
$394B
$1.12M 0.27%
9,490
– –
SRG
39
Seritage Growth Properties
SRG
$119M
$1.07M 0.26%
24,975
-4,050
-14% -$189K
HON icon
40
Honeywell
HON
$69.5B
$1.01M 0.24%
9,659
-580
-6% -$59K
VIVO
41
DELISTED
Meridian Bioscience Inc
VIVO
$914K 0.22%
51,635
+19,825
+62% +$348K
PG icon
42
Procter & Gamble
PG
$337B
$826K 0.2%
9,820
+30
+0.3% +$2.56K
CSX icon
43
CSX Corp
CSX
$96.5B
$693K 0.17%
57,900
-450
-0.8% -$5.04K
BBBY
44
DELISTED
Bed Bath & Beyond Inc
BBBY
$669K 0.16%
16,450
+975
+6% +$42.3K
T icon
45
AT&T
T
$177B
$657K 0.16%
20,466
– –
ITW icon
46
Illinois Tool Works
ITW
$81.1B
$640K 0.15%
5,225
-300
-5% -$36.2K
KMI icon
47
Kinder Morgan
KMI
$71.6B
$609K 0.15%
+29,425
New +$622K
KHC icon
48
Kraft Heinz
KHC
$29.1B
$603K 0.14%
6,911
– –
PAA icon
49
Plains All American Pipeline
PAA
$18B
$593K 0.14%
18,350
+600
+3% +$19K
BB icon
50
BlackBerry
BB
$4.51B
$576K 0.14%
83,625
-5,900
-7% -$43.8K
1
2
3 4

Similar funds

MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
PRC
Pearl River Capital Niles, Michigan $630M AUM 17.08% 1-Year Est. Return
SCM
Sahana Capital Management Greenwich, Connecticut $645M AUM 23.48% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return
PWS
Private Wealth Strategies New Albany, Ohio $498M AUM 17.23% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
JWM
Janiczek Wealth Management Denver, Colorado $477M AUM 15.17% 1-Year Est. Return
TWM
TMD Wealth Management Scottsdale, Arizona $456M AUM 11.92% 1-Year Est. Return

Greylin Investment Management's Q4 2016 Portfolio in Review

As of Q4 2016, Greylin Investment Management held 76 positions worth $417M, up 4% from $401M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Greylin Investment Management's Q4 2016 filing shows 2 new, 13 increased, 41 reduced and 8 closed positions. Its largest new stake was Teva Pharmaceuticals: 92,855 shares worth $3.37M. The largest sale was US Bancorp, an estimated $3.68M.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 36% a quarter earlier, followed by Energy and Healthcare.

  • Greylin Investment Management's largest Q4 2016 buy was Teva Pharmaceuticals: 92,855 shares worth $3.37M.
  • Greylin Investment Management added most to GSK in Q4 2016, an estimated $1.94M increase.
  • Greylin Investment Management's biggest Q4 2016 reduction was US Bancorp, cutting an estimated $3.68M.
  • Greylin Investment Management fully exited LinkedIn Corporation in Q4 2016, selling an estimated $3.09M.
  • Greylin Investment Management's ten largest holdings make up 76% of its $417M portfolio in Q4 2016.
  • Greylin Investment Management opened 2 new positions and closed 8 in Q4 2016.
  • Greylin Investment Management's portfolio value rose 4% quarter-over-quarter to $417M.

Based on Greylin Investment Management's 13F filing for Q4 2016, filed 18 Jan 2017.